Aptose biosciences stock

Stock analysis for Aptose Biosciences Inc (APTO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

13 May 2019 In this BBHIC interview, Aptose Biosciences CEO William Rice discusses the company's two clinical programs. Aptose Biosciences, Inc. (APTO) Stock Price, Quote ... Find the latest Aptose Biosciences, Inc. (APTO) stock quote, history, news and other vital information to help you with your stock trading and investing. APTO Stock Price | Aptose Biosciences Inc. Stock Quote (U ... Aptose Biosciences (APTO) Gets a Buy Rating from Oppenheimer In a report released yesterday, Matthew Biegler from Oppenheimer maintained a Buy rating on Aptose Biosciences (APTO), with a …

Aptose Biosciences, Inc. Common Shares (APTO) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.

APTO Aptose Biosciences Inc. Stock Quote Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Its clinical programs is APTO-253, which is a Phase Ib clinical trial for the treatment of patients with relapsed/refractory blood cancers, including acute myeloid Aptose Biosciences, Inc. Common Shares (APTO) Earnings ... Aptose Biosciences, Inc. is estimated to report earnings on 03/10/2020. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates.

Aptose Biosciences gained 0.87% in the last trading day (Friday, 3rd Apr 2020), rising from $5.75 to $5.80 During the day the stock fluctuated 6.64% from a day low at $5.57 to a day high of $5.94. APTO Stock Price Summary 30 day high of the APTO stock price was $8.75 and low was $4.27. 90 day high was $9.25 and low was $4.27.

APS.CA | Aptose Biosciences Inc. Stock Price & News - WSJ

Why Aptose Biosciences Shares Are Jumping Today | The ...

Company Name: Aptose Biosciences Inc., Stock Symbol: APTO, Industry: Biotechs, Total Posts: 131, Last Post: 3/15/2020 7:16:09 PM. Aptose Biosciences Inc quote is equal to 6.020 USD at 2020-04-06. Based on our forecasts, a long-term increase is expected, the "APTO" stock price prognosis for  7 Mar 2020 Aptose Biosciences Inc. (APTO) is priced at $8.10 after the most recent trading session. At the very opening of the session, the stock price was  16 Mar 2020 Aptose Biosciences Inc. (Aptose) is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs 

Aptose Biosciences Inc quote is equal to 6.020 USD at 2020-04-06. Based on our forecasts, a long-term increase is expected, the "APTO" stock price prognosis for 

If Aptose Biosciences Inc (TSX:APS) is successful at treating life-threatening cancers, the stock could see a huge increase in value, and shareholders will be. 30 Jul 2015 We apologize for any inconvenience. Refresh or try again later. Summary. News. Profile. Financials. Events. Ownership. Options  13 May 2019 In this BBHIC interview, Aptose Biosciences CEO William Rice discusses the company's two clinical programs. Aptose Biosciences, Inc. (APTO) Stock Price, Quote ... Find the latest Aptose Biosciences, Inc. (APTO) stock quote, history, news and other vital information to help you with your stock trading and investing. APTO Stock Price | Aptose Biosciences Inc. Stock Quote (U ... Aptose Biosciences (APTO) Gets a Buy Rating from Oppenheimer In a report released yesterday, Matthew Biegler from Oppenheimer maintained a Buy rating on Aptose Biosciences (APTO), with a …

About :: Aptose Biosciences Inc. (APTO) Aptose Biosciences is a clinical-stage biotechnology company focused on developing personalized therapies addressing unmet medical needs in oncology. Aptose Biosciences Inc Stock Quote: APTO Stock News ... Nov 06, 2019 · APTO, Aptose Biosciences Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines